UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000051975 |
|---|---|
| Receipt number | R000059238 |
| Scientific Title | Optimal therapeutic strategies with CDK4/6 inhibitors based on the real world evidence in patients with HR-positive/HER2-negative advanced and metastatic breast cancer |
| Date of disclosure of the study information | 2023/08/25 |
| Last modified on | 2025/09/19 18:01:18 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2023/08/22 16:38:53 | ||
| 2 | Update | 2024/03/21 17:41:36 | Recruitment status |
|
| 3 | Update | 2025/07/30 14:52:50 | Public title Scientific Title |
|
| 4 | Update | 2025/07/30 14:54:26 | Last follow-up date |
|
| 5 | Update | 2025/07/30 14:59:02 | Email |
|
| 6 | Update | 2025/09/19 16:41:37 | Institutions |
|
| 7 | Update | 2025/09/19 16:50:54 | Recruitment status |
|
| 8 | Update | 2025/09/19 18:01:18 | URL releasing protocol Publication of results URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Date of the first journal publication of results Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures Plan to share IPD Plan to share IPD |
